Wall Street Zen Downgrades Nukkleus (NASDAQ:DFNS) to Strong Sell

Nukkleus (NASDAQ:DFNS) was downgraded by Wall Street Zen from a “sell” rating to a “strong sell” rating in a note issued to investors on Saturday, Wall Street Zen reports.

Several other research analysts also recently commented on the stock. Weiss Ratings downgraded shares of Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a research note on Monday, July 20th. Noble Financial upgraded Nukkleus to a “strong-buy” rating in a report on Monday, June 29th. One investment analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy”.

Nukkleus Stock Performance

Shares of NASDAQ DFNS opened at $10.24 on Friday. The stock has a market capitalization of $17.00 million, a P/E ratio of -0.03 and a beta of -5.88. The company has a debt-to-equity ratio of 0.07, a current ratio of 0.14 and a quick ratio of 0.11. The business’s 50 day moving average is $22.31 and its two-hundred day moving average is $71.57. Nukkleus has a 1-year low of $3.70 and a 1-year high of $1,948.75.

Nukkleus (NASDAQ:DFNS) last posted its quarterly earnings data on Wednesday, August 19th. The company reported ($173.80) EPS for the quarter, missing the consensus estimate of ($3.11) by ($170.69). The business had revenue of $4.00 million for the quarter, compared to the consensus estimate of $4.50 million. As a group, research analysts expect that Nukkleus will post -3.9 EPS for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. BNP Paribas Financial Markets acquired a new stake in Nukkleus in the second quarter worth about $56,000. State Street Corp increased its stake in Nukkleus by 70.7% during the 4th quarter. State Street Corp now owns 17,863 shares of the company’s stock valued at $72,000 after purchasing an additional 7,400 shares in the last quarter. Price T Rowe Associates Inc. MD purchased a new position in shares of Nukkleus in the fourth quarter worth $57,000. GM Advisory Group LLC acquired a new stake in shares of Nukkleus during the fourth quarter worth $56,000. Finally, Millennium Management LLC acquired a new position in shares of Nukkleus in the 4th quarter valued at $60,000. 12.47% of the stock is currently owned by hedge funds and other institutional investors.

About Nukkleus

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.